Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for Prevention of POCD in Elderly Orthopaedic Patients
NCT02892916Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2017
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketamine in Post-operative cognitive dysfunction (POCD), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Proportion of early postoperative cognitive dysfunction at 90 days. Started Mar 2017; status: completed.
02
Drugs
ketamine
03
Conditions
Post-operative cognitive dysfunction (POCD)
Beyond the preview
Go deeper on NCT02892916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02892916.